Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis

European Journal of Heart Failure

Volumn 10, Issue 10, 2008, Pages 1007-1014

  de Sousa, Marcos R ^a   Morillo, Carlos A ^b   Rabelo, Fábio T ^a   Nogueira Filho, Antônio M ^a   Ribeiro, Antonio L P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Death, sudden, cardiac; Heart failure; Prognosis; Tachycardia, ventricular; Ventricular dysfunction

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; HEART FAILURE; HUMANS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 53249107556     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.07.002     Document Type: Article

References (50)

1. Bryant J., Brodin H., Loveman E., and Clegg A. Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation. Int J Technol Assess Health Care 23 1 (2007) 63-70
2. Chen L., and Hay J.W. Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure. Cardiov Drugs Ther 18 2 (2004) 161-170
3. Sanders G.D., Hlatky M.A., and Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353 14 (2005) 1471-1480
4. Eisenberg M.J. Risk stratification for arrhythmic events: are the bangs worth the bucks?. J Am Coll Cardiol 38 7 (2001) 1912-1915
5. Buxton A.E., and Moss A.J. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?. Circulation 111 (2005) 2537-2549
6. Prystowsky E.N. Primary prevention of sudden cardiac death: the time of your life. Circulation 109 9 (2004) 1073-1075
7. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237
8. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannon D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 12 (2002) 877-883 21
9. Uslan D.Z., Sohail M.R., St Sauver J.L., Friedman P.A., Hayes D.L., Stoner S.M., et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Int Med 167 7 (2007) 669-675
10. Al-Khatib S.M., Sanders G.D., Bigger J.T., Buxton A.E., Califf R.M., Carlson M., et al. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J 153 6 (2007) 941-950
11. La Rovere M.T., Pinna G.D., Maestri R., Mortara A., Capomolla S., Febo O., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 4 (2003) 565-570
12. Moore R.K., Groves D.G., Barlow P.E., Fox K.A., Shah A., Nolan J., et al. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 8 6 (2006) 585-590
13. Salerno-Uriarte J.A., De Ferrari G.M., Klersy C., Pedretti R.F.E., Tritto M., Sallusti L., et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy. J Am Coll Cardiol 50 (2007) (published online before print October 29, 2007)
14. Katritsis D.G., and Camm A.J. Nonsustained ventricular tachycardia: where do we stand?. Eur Heart J 25 13 (2004) 1093-1099
15. Wilczynski N.L., and Haynes R.B. Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey. BMC Med 2 (2004) 23
16. Bailey J.J., Berson A.S., Handelsman H., and Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38 7 (2001) 1902-1911
17. Egger M., and Smith G.D. Bias in location and selection of studies. BMJ 316 7124 (Jan 3 1998) 61-66 Clinical research ed.
18. Moayyedi P. Meta-analysis: can we mix apples and oranges?. Am J Gastroent 99 12 (2004) 2297-2301
19. Zamora J., Abraira V., Muriel A., Khan K.S., and Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6 (2006) 31
20. Devillé W.L., Buntinx F., Bouter L.M., Montori V.M., de Vet H.C., van der Windt D.A., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2 (2002) 9
21. Moses L.E., Shapiro D, and Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12 14 (1993) 1293-1316
22. Lijmer J.G., Bossuyt P.M., and Heisterkamp S.H. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21 11 (2002) 1525-1537
23. Irwig L., Tosteson A.N., Gatsonis C., Lau J., Colditz G., Chalmers T.C., et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120 8 (1994) 667-676
24. Dinnes J., Deeks J., Kirby J., and Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 9 12 (Mar 2005) 1-113 iii
25. Gradman A., Deedwania P., Cody R., Massie B., Packer M., Pitt B., et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 14 3 (1989) 564-570
26. Watanabe J., Shinozaki T., Shiba N., Fukahori K., Koseki Y., Karibe A., et al. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail 8 3 (2006) 237-422
27. Szabo B.M., van Veldhuisen D.J., Crijns H.J., Wiesfeld A.C., Hillege H.L., and Lie K.I. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J 15 7 (1994) 928-933
28. Doval H.C., Nul D.R., Grancelli H.O., Varini S.D., Soifer S., Corrado G., et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 94 12 (1996) 3198-3203
29. Becker R., Haass M., Ick D., Krueger C., Bauer A., Senges-Becker J.C., et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Bas Res Cardiol 98 4 (2003) 259-266
30. Kearney M.T., Fox K.A., Lee A.J., Brooksby W.P., Shah A.M., Flapan A., et al. Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 90 10 (2004) 1137-1143
31. Fauchier L., Douglas J., Babuty D., Cosnay P., and Fauchier J.P. QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. Eur J Heart Fail 7 2 (2005) 277-282
32. Iacoviello M., Forleo C., Guida P., Romito R., Sorgente A., Sorrentino S., et al. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 50 3 (2007) 225-231
33. De Maria R., Gavazzi A., Caroli A., Ometto R., Biagini A., and Camerini F. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 69 (1992) 1451-1457
34. Teerlink J.R., Jalaluddin M., Anderson S., Kukin M.L., Eichhorn E.J., Francis G., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 101 1 (2000) 40-46
35. Grimm W., Christ M., Bach J., Muller H.H., and Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108 23 (2003) 2883-2891
36. Knottnerus J.A. The evidence base of clinical diagnosis (2002), BMJ Publishing Group, London 185
37. Buxton A.E., Lee K.L., Hafley G.E., Pires L.A., Fisher J.D., Gold M.R., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50 12 (2007) 1150-1157
38. de Vreede-Swagemakers J.J., Gorgels A.P., Dubois-Arbouw W.I., van Ree J.W., Daemen M.J., Houben L.G., et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30 6 (1997) 1500-1555
39. Gorgels A.P., Gijsbers C., de Vreede-Swagemakers J., Lousberg A., and Wellens H.J. Out-of-hospital cardiac arrest - the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24 13 (2003) 1204-1209
40. Ellenbogen K.A., Levine J.H., Berger R.D., Daubert J.P., Winters S.L., Greenstein E., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 6 (2006) 776-782
41. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 1 (2005) 75-82
42. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 26 (1996) 1933-1940
43. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 25 (1999) 1882-1890
44. Exner D.V., Kavanagh K.M., Slawnych M.P., Mitchell L.B., Ramadan D., Aggarwal S.G., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 50 24 (2007 Dec 11) 2275-2284
45. Cardiac defibrillators, Kant, and the categorical imperative. Ribeiro ALP, Duarte RH. Am Heart J article in press, doi:10.1016/j.ahj.2007.10.036.
46. Smidt N., Rutjes A.W., van der Windt D.A., Ostelo R.W., Reitsma J.B., Bossuyt P.M., et al. Quality of reporting of diagnostic accuracy studies. Radiology 235 2 (2005) 347-353
47. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. Croat Med J 44 5 (2003) 639-650
48. Irwig L., Bossuyt P., Glasziou P., Gatsonis C., and Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324 7338 (Mar 16 2002) 669-671 Clinical research ed.
49. Nisam S., and Breithardt G. Lessons learned from neutral trials. Europace 8 (2006) 393-397
50. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488